Send us a link
The world’s most potent technologists are stranded in today’s innovation ecosystem.
It’s another blow to an industry that has been hammered in the U.S. and Europe, leaving a huge opportunity for China to emerge as a global leader in nuclear technology.
The president’s proposed cuts to research funding would cripple American innovation. We should be spending more on R&D, not less.
As climate change accelerates, a handful of scientists are eager to move ahead with experiments testing ways to counteract warming artificially.
There’s a big problem with AI: even its creators can’t explain how it works
Entrepreneurs are betting on apps that improve—or just replace—prescription medication.
Berners-Lee says Web access is a human right—and the technology he created needs a rethink.
10 breakthrough technologies that will affect the economy and politics, improve medicine, or influence our culture.
Surging investment in machine learning is vaulting Google into the scientific stratosphere.
New techniques being used to produce our food or shape the environment raise regulatory questions.
The dispute between researchers at UC Berkeley and the Broad Institute over the invention of the powerful gene-editing technique has been decided.
The work could lead to a new approach to the study of what is possible, and how it follows from what already exists.
The technique could be faster and more versatile than developing GMO crops from scratch.
Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google’s anti-aging spinout Calico is rich enough to find out.
New evidence in the battle to control a gene-editing technology that is worth billions.
If academic discoveries turn out to be wrong, one drug company wants its money back.
The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
The way scientific information diffuses through the knowledge economy is changing, and the first evidence from Wikipedia shows how.
For $25 a year, Google will keep a copy of any genome in the cloud.
Note from Arthur Obermayer, friend of the author: In 1959, I worked as a scientist at Allied Research Associates in Boston. The company was an MIT spinoff that originally focused on the effects of nuclear weapons on aircraft structures.
